The COVID-19 pandemic has impacted the healthcare field through reductions in patient volume and higher practice costs. How will these economic challenges change health policy and alter the future of healthcare? President of the American Medical Association Dr. Susan R. Bailey joins Dr. Matt Birnholz to discuss their recent survey.
Appointed member to the President's Cancer Panel and Clinical Professor of Medicine at Thomas Jefferson University, Dr. Edith Mitchell, shares what the panel recommends to close gaps in cancer screening in the U.S.—with a focus on colorectal cancer—to improve access for all patients.
With telehealth services expanding during the COVID-19 pandemic, has our access to them changed? To better understand this, Dr. Charles Turck meets with Sandy Marks, Kim Horvath, and Kyle Thomson from the AMA to explore what’s been done to provide Medicare coverage during a public health emergency and what’s on the horizon for telehealth access.
The No Surprises Act aims to protect consumers from surprise medical bills. But how exactly does it go about doing that, and what’s the current status of its implementation? Joining Dr. Charles Turck to share progress and challenges associated with the No Surprises Act is Ms. Emily Carroll, a senior legislative attorney for the American Medical Association's Advocacy Resource Center.
The prior authorization cost control process can be a burden on clinicians and lead to delayed treatment for patients. But the AMA’s recent advocacy efforts may help reform the process. Dr. Charles Turck meets with Emily Carroll, Heather McComas, and Chris Sherin to dive into these reforms and their impact at the state and federal levels.
The COVID-19 pandemic led many clinicians to make life-altering decisions. Dr. Ana Zamora, a pulmonary disease and critical care specialist, discusses her work with Locum Tenens and why she decided it was time for a change.
A locum tenens opportunity brought a physician to New Zealand, but the onset of the COVID-19 pandemic gave her the opportunity to stay. Dr. Dalilah Restrepo, a former infectious disease specialist at the AHF Healthcare Center, discusses her locum tenens experience and discusses how New Zealand has responded to the pandemic.
Following the approval of the first COVID-19 vaccine, mass-vaccination has made approving a vaccine difficult. How are the Food and Drug Administration and the Centers for Disease Control deciding on which vaccinations to authorize? Dr. Mira Irons and Shannon Curtis of the American Medical Association join Dr. Charles Turck to discuss authorization processes and recommendations for COVID-19 vaccines.
The U.S. Food and Drug Administration announced its approval of Ebanga (Ansuvimab-zykl) for the treatment of the ebola virus infection in adults and children. To learn more about the second ebolavirus treatment to receive approval, Dr. Linda Bernstein walks us through this new drug.
Published December 29, 2020
As a growing number of pharmaceutical companies refuse to provide discounts to 340B hospitals for drugs dispensed at community-based pharmacies, a federal lawsuit is challenging the U.S. Department of Health and Human Services in order to fight for patient communities harmed by this refusal. On this episode of The Drug Report, Dr. Linda Bernstein dives into this lawsuit.
With E&M coding changes taking effect January 1, 2021, the AMA offers tools and resources for physician implementation. Dr. Kathleen Blake, Vice President of Healthcare Quality at the American Medical Association, joins Dr. Jennifer Caudle to share what we can expect.
Stay up to date
For any inquiries, please email us at hello@podcastworld.io